Mark Rigby

Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients

Mark Rigby, Kristina M. Harris, Ashley Pinckney et al. · Journal of Clinical Investigation · 2015 · 292 citations · Full text

Medicine, Endocrinology, Immunology +17

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes

Teresa Quattrin, Michael J. Haller, Andrea K. Steck et al. · New England Journal of Medicine · 2020 · 252 citations

Medicine, Endocrinology, Pharmacotherapy +17

Ultrasound-guided central venous catheter placement decreases complications and decreases placement attempts compared with the landmark technique in patients in a pediatric intensive care unit*

Curt D. Froehlich, Mark Rigby, Eli S. Rosenberg et al. · Critical Care Medicine · 2009 · 249 citations

Medicine, Pediatrics, Surgery +17

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

Mark Rigby, Linda A. DiMeglio, Marc Rendell et al. · The Lancet Diabetes & Endocrinology · 2013 · 206 citations · Full text

Life Sciences, Endocrinology, Immunology +17

A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

María J. Redondo, Susan Geyer, Andrea K. Steck et al. · Diabetes Care · 2018 · 169 citations · Full text

Life Sciences, Endocrinology, Genetics +17